Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / *W EXP 05/18/201
-
Total 13F shares
-
915,702
-
Share change
-
-183,590
-
Total reported value
-
$42,000
-
Price per share
-
$0.05
-
Number of holders
-
6
-
Value change
-
-$3,000
-
Number of buys
-
2
-
Number of sells
-
2
Institutional Holders of ONCOBIOLOGICS INC - *W EXP 05/18/201 (ONSIZ) as of Q1 2018
As of 31 Mar 2018,
ONCOBIOLOGICS INC - *W EXP 05/18/201 (ONSIZ) was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
915,702 shares.
The largest 6 holders included
Cormorant Asset Management, LP, venBio Select Advisor LLC, Marshall Wace North America L.P., PointState Capital LP, Monashee Investment Management LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
6
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.